These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28606734)

  • 21. Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis.
    Zhou B; Margariti A; Zeng L; Xu Q
    Cardiovasc Res; 2011 Jun; 90(3):413-20. PubMed ID: 21233251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone Acetylation Enzymes Coordinate Metabolism and Gene Expression.
    Shen Y; Wei W; Zhou DX
    Trends Plant Sci; 2015 Oct; 20(10):614-621. PubMed ID: 26440431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of histone deacetylases.
    Huang Y; Shaw PG; Davidson NE
    Methods Mol Biol; 2011; 791():297-311. PubMed ID: 21913088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs.
    Vaquero A; Sternglanz R; Reinberg D
    Oncogene; 2007 Aug; 26(37):5505-20. PubMed ID: 17694090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cleavage and cytoplasmic relocalization of histone deacetylase 3 are important for apoptosis progression.
    Escaffit F; Vaute O; Chevillard-Briet M; Segui B; Takami Y; Nakayama T; Trouche D
    Mol Cell Biol; 2007 Jan; 27(2):554-67. PubMed ID: 17101790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HDAC inhibitors: a potential new category of anti-tumor agents.
    Pan LN; Lu J; Huang B
    Cell Mol Immunol; 2007 Oct; 4(5):337-43. PubMed ID: 17976313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histones and lung cancer: Are the histone deacetylases a promising therapeutic target?
    Petta V; Gkiozos I; Strimpakos A; Syrigos K
    Cancer Chemother Pharmacol; 2013 Nov; 72(5):935-52. PubMed ID: 24036844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aurora-B and HDAC synergistically regulate survival and proliferation of lymphoma cell via AKT, mTOR and Notch pathways.
    Wang C; Chen J; Cao W; Sun L; Sun H; Liu Y
    Eur J Pharmacol; 2016 May; 779():1-7. PubMed ID: 26638998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histone Deacetylases and Their Regulatory MicroRNAs in Hepatocarcinogenesis.
    Kim HS; Shen Q; Nam SW
    J Korean Med Sci; 2015 Oct; 30(10):1375-80. PubMed ID: 26425032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complex neuroprotective and neurotoxic effects of histone deacetylases.
    Thomas EA; D'Mello SR
    J Neurochem; 2018 Apr; 145(2):96-110. PubMed ID: 29355955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic modifications by histone deacetylases: Biological implications and therapeutic potential in liver fibrosis.
    Chen PJ; Huang C; Meng XM; Li J
    Biochimie; 2015 Sep; 116():61-9. PubMed ID: 26116886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of histone deacetylases in melanoma-a perspective from bench to bedside.
    Hornig E; Heppt MV; Graf SA; Ruzicka T; Berking C
    Exp Dermatol; 2016 Nov; 25(11):831-838. PubMed ID: 27792246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Class I histone deacetylases regulate p53/NF-κB crosstalk in cancer cells.
    Schäfer C; Göder A; Beyer M; Kiweler N; Mahendrarajah N; Rauch A; Nikolova T; Stojanovic N; Wieczorek M; Reich TR; Tomicic MT; Linnebacher M; Sonnemann J; Dietrich S; Sellmer A; Mahboobi S; Heinzel T; Schneider G; Krämer OH
    Cell Signal; 2017 Jan; 29():218-225. PubMed ID: 27838375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The HAT/HDAC interplay: multilevel control of STAT signaling.
    Icardi L; De Bosscher K; Tavernier J
    Cytokine Growth Factor Rev; 2012 Dec; 23(6):283-91. PubMed ID: 22989617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rho-associated coiled-coil kinase (ROCK) signaling and disease.
    Schofield AV; Bernard O
    Crit Rev Biochem Mol Biol; 2013; 48(4):301-16. PubMed ID: 23601011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone deacetylase inhibitors: mechanisms and clinical significance in cancer: HDAC inhibitor-induced apoptosis.
    Shankar S; Srivastava RK
    Adv Exp Med Biol; 2008; 615():261-98. PubMed ID: 18437899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation.
    McKinsey TA; Zhang CL; Lu J; Olson EN
    Nature; 2000 Nov; 408(6808):106-11. PubMed ID: 11081517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of HDACs in optic nerve damage-induced nuclear atrophy of retinal ganglion cells.
    Schmitt HM; Schlamp CL; Nickells RW
    Neurosci Lett; 2016 Jun; 625():11-5. PubMed ID: 26733303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein deacetylases: enzymes with functional diversity as novel therapeutic targets.
    Yoshida M; Shimazu T; Matsuyama A
    Prog Cell Cycle Res; 2003; 5():269-78. PubMed ID: 14593721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel Insights into the Roles of Rho Kinase in Cancer.
    Wei L; Surma M; Shi S; Lambert-Cheatham N; Shi J
    Arch Immunol Ther Exp (Warsz); 2016 Aug; 64(4):259-78. PubMed ID: 26725045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.